KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $35.7 million.

  • Idexx Laboratories' Current Deferred Revenue fell 713.17% to $35.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.7 million, marking a year-over-year decrease of 713.17%. This contributed to the annual value of $33.8 million for FY2024, which is 913.03% down from last year.
  • Latest data reveals that Idexx Laboratories reported Current Deferred Revenue of $35.7 million as of Q3 2025, which was down 713.17% from $36.3 million recorded in Q2 2025.
  • Idexx Laboratories' 5-year Current Deferred Revenue high stood at $41.6 million for Q1 2021, and its period low was $33.8 million during Q4 2024.
  • In the last 5 years, Idexx Laboratories' Current Deferred Revenue had a median value of $38.0 million in 2024 and averaged $38.4 million.
  • Per our database at Business Quant, Idexx Laboratories' Current Deferred Revenue surged by 1325.27% in 2021 and then plummeted by 913.03% in 2024.
  • Idexx Laboratories' Current Deferred Revenue (Quarter) stood at $40.0 million in 2021, then fell by 5.24% to $37.9 million in 2022, then dropped by 1.96% to $37.2 million in 2023, then dropped by 9.13% to $33.8 million in 2024, then grew by 5.6% to $35.7 million in 2025.
  • Its last three reported values are $35.7 million in Q3 2025, $36.3 million for Q2 2025, and $35.0 million during Q1 2025.